Evidence map›Paper›PMID 39859557›Full record

ReviewInternational journal of molecular sciences2025

Alcohol Consumption and Autoimmune Diseases.

Sergio Terracina, Brunella Caronti, Marco Lucarelli, Silvia Francati, Maria Grazia Piccioni, Luigi Tarani, Mauro Ceccanti, Micaela Caserta, Loredana Verdone, Sabrina Venditti and 2 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sergio TerracinaDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-0748-8825
Brunella CarontiDepartment of Human Neurosciences, Sapienza University Hospital of Rome, 00185 Rome, Italy.
Marco LucarelliDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-5538-2494
Silvia FrancatiDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0009-0009-7672-6696
Maria Grazia PiccioniDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00161 Rome, Italy.
Luigi TaraniDepartment of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-5958-9364
Mauro CeccantiSITAC, Società Italiana per il Trattamento dell'Alcolismo e le sue Complicanze, 00185 Rome, Italy.ORCID 0000-0001-9981-8715
Micaela CasertaInstitute of Molecular Biology and Pathology (IBPM-CNR), 00161 Rome, Italy.
Loredana VerdoneInstitute of Molecular Biology and Pathology (IBPM-CNR), 00161 Rome, Italy.
Sabrina VendittiDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00161 Rome, Italy.
Marco FioreInstitute of Biochemistry and Cell Biology (IBBC-CNR), c/o Department of Sensory Organs, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-6806-9715
Giampiero FerragutiDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-6129-4071

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol is the second-most misused substance after tobacco. It has been identified as a causal factor in more than 200 diseases and 5.3% of all deaths and is associated with significant behavioral, social, and economic difficulties. As alcohol consumption may modulate the immune system's regulatory mechanisms to avoid attacking the body's tissues, it has been proven to play a dichotomic role in autoimmune diseases (ADs) based on the quantity of consumption. In this review, we report updated evidence on the role of alcohol in ADs, with a focus on alcohol addiction and the human biological immune system and the relationship between them, with alcohol as a risk or protective factor. Then, in this narrative review, we report the main evidence on the most studied ADs where alcohol represents a key modulator, including autoimmune thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, diabetes, allergic rhinitis, and primary biliary cholangitis. Alcohol at low-moderate dosages seems mostly to have a protective role in these diseases, while at higher dosages, the collateral risks surpass possible benefits. The specific mechanisms by which low-to-moderate alcohol intake relieves AD symptoms are not yet fully understood; however, emerging studies suggest that alcohol may have a systemic immunomodulatory effect, potentially altering the balance of anti-inflammatory innate and adaptive immune cells, as well as cytokines (via the NF-κB or NLRP3 pathways). It might influence the composition of the gut microbiome (increasing amounts of beneficial gut microbes) and the production of their fatty acid metabolites, such as short-chain fatty acids (SCFAs) and polyunsaturated fatty acids (PUFAs), as well as elevated concentrations of acetate, high-density lipoprotein (HDL), and nitric oxide (NO). Unfortunately, a definite acceptable daily intake (ADI) of ethanol is complicated to establish because of the many mechanisms associated with alcohol consumption such that despite the interesting content of these findings, there is a limit to their applicability and risks should be weighed in cases of alcoholic drinking recommendations. The aim of future studies should be to modulate those beneficial pathways involved in the alcohol-protective role of ADs with various strategies to avoid the risks associated with alcohol intake.

Indexed as

Alcohol DrinkingAutoimmune DiseasesAnimalsHumansalcoholautoimmunityimmune systeminflammationmetabolism

Identifiers

PMID39859557
PMCPMC11766456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.